Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study.
Retinol binding protein 4 (RBP4) is a recently identified adipokine that is elevated in patients with obesity or type 2 diabetes. A growing body of research has shown that RBP4 is associated with several types of cancer. However, no studies have investigated the relationship between serum RBP4 level...
Main Authors: | Congcong Jiao, Lianhua Cui, Aiguo Ma, Na Li, Hongzong Si |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5176270?pdf=render |
Similar Items
-
Elevated Serum Retinol Binding Protein 4 is Associated with the Risk of Diabetic Cardiomyopathy
by: Haihua Shan, et al.
Published: (2022-03-01) -
Elevated serum triglyceride and retinol-binding protein 4 levels associated with fructose-sweetened beverages in adolescents.
by: Te-Fu Chan, et al.
Published: (2014-01-01) -
Serum retinol-binding protein 4 levels in polycystic ovary syndrome
by: Shilpa Lingaiah, et al.
Published: (2019-05-01) -
Retinol and retinol binding protein 4 levels and COVID-19: a Mendelian randomization study
by: Haixia Wang, et al.
Published: (2024-04-01) -
Assessment of Serum Retinol Binding Protein 4 in Patients with Hepatocellular Carcinoma
by: Yehia Mohamed El Shazly, et al.
Published: (2018-10-01)